Artiva Biotherapeutics (ARTV) Net Margin (2023 - 2024)
Artiva Biotherapeutics (ARTV) has disclosed Net Margin for 2 consecutive years, with 5514.74% as the latest value for Q1 2024.
- Quarterly Net Margin changed N/A to 5514.74% in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 24675.3% through Dec 2024, changed N/A year-over-year, with the annual reading at 26045.02% for FY2024, 2595927.0% down from the prior year.
- Net Margin for Q1 2024 was 5514.74% at Artiva Biotherapeutics, down from 563.87% in the prior quarter.
- The five-year high for Net Margin was 563.87% in Q4 2023, with the low at 5514.74% in Q1 2024.